"10.1371_journal.pone.0015679","plos one","2010-12-20T00:00:00Z","Laura D'Castro; Adam Wenborn; Nathalie Gros; Susan Joiner; Sabrina Cronier; John Collinge; Jonathan D F Wadsworth","MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, United Kingdom","Conceived and designed the experiments: LD'C AW NG SJ SC JC JDFW. Performed the experiments: LD'C AW NG SC SJ. Analyzed the data: LD'C AW NG SJ SC JC JDFW. Wrote the paper: LD'C JC JDFW.","The authors have read the journal's policy and have the following conflicts. J.C. is a Director and J.C. and J.D.F.W. are shareholders and consultants of D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, decontamination, and therapeutics. D-Gen markets the ICSM35 and ICSM18 antibodies used in this study. This does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials.","2010","12","Laura D'Castro","LDC",7,TRUE,7,5,7,3,TRUE,TRUE,FALSE,0,NA,FALSE
